Results 91 to 100 of about 11,910 (159)

New Breakthroughs in the Diagnosis of Leptomeningeal Carcinomatosis: A Review of Liquid Biopsies of Cerebrospinal Fluid

open access: yes
Leptomeningeal carcinomatosis represents a terminal stage and is a devastating complication of cancer. Despite its high incidence, current diagnostic methods fail to accurately detect this condition in a timely manner.
Altawalbeh, Ghaith   +5 more
core   +1 more source

ePosters Virtual

open access: yes
European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Outcome and prognostic factors following palliative craniospinal irradiation for leptomeningeal carcinomatosis

open access: yes, 2019
Leptomeningeal carcinomatosis (LC) is a severe complication of metastatic tumor spread to the central nervous system. Prognosis is dismal with a median overall survival (OS) of ~10-15 weeks.
Böhm, Karina   +15 more
core   +1 more source

Papilledema and bilateral optic neuropathy: dual mechanism for visual loss in patient with leptomeningeal carcinomatosis

open access: yes, 2019
Leptomeningeal carcinomatosis (LC) is rare complication of cancer involving spread of cancer cells into central nervous system via cerebrospinal fluid (CSF).
Henry Liu; Mohammed Alfalah; Paul Freund; Edward Margolin
core  

Quantitative Cerebrospinal Fluid Area Analysis for Sooner Detection of Communicating Hydrocephalus in Patients with Leptomeningeal Carcinomatosis

open access: yes, 2023
A diagnosis of leptomeningeal carcinomatosis has important prognostic and therapeutic implications. Patients with LC frequently develop neurologic symptoms secondary to related to elevated intracranial pressure including headaches, blurred vision, and ...
Casey Judge; Michael Lee; Collin McClelland
core  

Novel Anterior Brainstem Magnetic Resonance Imaging Findings in Non-Small Cell Lung Cancer with Leptomeningeal Carcinomatosis

open access: yes, 2017
Leptomeningeal carcinomatosis (LC) is found in around 4% of patients with non-small cell lung cancer (NSCLC). The most common radiological finding of LC is diffuse leptomeningeal enhancement on contrast-enhanced brain magnetic resonance imaging (MRI ...
Shy-Chyi Chin   +7 more
core   +1 more source

A Diagnostic Quartet in Leptomeningeal Infiltration of the Optic Nerve Sheath

open access: yes, 1996
A rare case of optic leptomeningeal carcinomatosis secondary to a rectal adenocarcinoma is recorded. The presentation of rectal disease with blindness is unique. A diagnostic quartet of symptoms and signs of leptomeningeal infiltration of the optic nerve
Robert McFadzean, FRCSEd; Donal Brosnahan, FRCSEd; David Doyle, MD; James Going, MRCPath; Donald Hadley, FRCR; William Lee, MD
core  

Cisplatin and temozolomide combination in the treatment of leptomeningeal carcinomatosis from ethmoid sinus intestinal-type adenocarcinoma

open access: yes, 2010
Intestinal-type adenocarcinoma of the nasal cavities and paranasal sinuses is a relatively rare tumor. Standard therapeutic modalities include surgery followed by radiotherapy, sometimes with chemotherapy treatment.
DELLA PUPPA, ALESSANDRO   +34 more
core   +1 more source

Application of 3D fast spin-echo T1 black-blood imaging in the diagnosis and prognostic prediction of patients with leptomeningeal carcinomatosis

open access: yes, 2018
BACKGROUND AND PURPOSE: Contrast-enhanced 3D fast spin-echo T1 black-blood imaging selectively suppresses the signal of blood flow and could provide a higher contrast-to-noise ratio compared with contrast-enhanced 3D ultrafast gradient recalled echo ...
Lee E.   +9 more
core   +1 more source

Palliative Osimertinib Rechallenge Achieving Rapid Improvement in Leptomeningeal Carcinomatosis After Prior Osimertinib‐Induced ILD

open access: yesRespirology Case Reports
A patient with EGFR‐mutant lung cancer developed leptomeningeal carcinomatosis years after osimertinib‐induced ILD. With no other treatment options, palliative osimertinib rechallenge led to rapid neurological improvement and radiological response ...
Akina Nigi   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy